SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-006883
Filing Date
2021-02-19
Accepted
2021-02-19 14:07:57
Documents
13
Period of Report
2021-02-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20210219.htm   iXBRL 8-K 33742
2 EX-99.1 dvax-ex991_6.htm EX-99.1 25868
  Complete submission text file 0001564590-21-006883.txt   194180

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210219.xsd EX-101.SCH 5772
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210219_lab.xml EX-101.LAB 19478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210219_pre.xml EX-101.PRE 11627
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20210219_htm.xml XML 3558
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 21654287
SIC: 2834 Pharmaceutical Preparations